Kaposi's sarcoma differential diagnosis: Difference between revisions

	Kaposi's sarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Kaposi's sarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Kaposi's sarcoma differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Kaposi's sarcoma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Kaposi's sarcoma differential diagnosis
CDC on Kaposi's sarcoma differential diagnosis
Kaposi's sarcoma differential diagnosis in the news
Blogs on Kaposi's sarcoma differential diagnosis
Directions to Hospitals Treating Kaposi's sarcoma
Risk calculators and risk factors for Kaposi's sarcoma differential diagnosis

VisualWikitext

Revision as of 03:56, 20 September 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Haytham Allaham, M.D. [3]

Overview

Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement, such as bacillary angiomatosis, AIDS-related lymphoma, and seborrheic keratosis.^[1]^[2]^[3]

Differentiating Kaposi's Sarcoma from other Diseases

Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement, such as:^[1]^[2]^[3]

Kaposi's sarcoma cutaneous lesions must be differentiated from:

Bacillary angiomatosis
Arteriovenous malformation
Acroangiodermatitis
Masson's hemangioma
Angiosarcoma
Seborrheic keratosis
Erythematous lupus
Pigmented purpuric dermatosis
Pyogenic granuloma
Benign lymphangioendothelioma
Cavernous hemangioma
Sarcomatoid carcinoma
Spindle cell hemangioendothelioma

Kaposi's sarcoma pulmonary lesions must be differentiated from:

Kaposi's sarcoma gastrointestinal lesions must be differentiated from:

					Symptoms			Signs				CBC			LFT	ESR/CRP	Histopathology
Diseases	Etiology	Congenital	Acquied	Demography	Clinical manifestations							Lab findings						Gold standard diiagnosis	Additional findings
					Appearance	Fever	Bleeding	BP	Hepatosplenomegaly	Lymphadenopathy	Other	WBC	Hb	Plt	LFT	ESR/CRP	Histopathology
Bacillary angiomatosis	HIV Chronic lymphocytic leukemia Cytotoxic chemotherapy Organ transplantation
Arteriovenous malformation
Acroangiodermatitis
Angiosarcoma
Masson's hemangioma
Seborrheic keratosis
Systemic lupus erythematosus (SLE)
Pigmented purpuric dermatosis
Pyogenic granuloma
Benign lymphangioendothelioma
Cavernous hemangioma
Sarcomatoid carcinoma
Spindle cell hemangioendothelioma

References

↑ ^1.0 ^1.1 Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016
↑ ^2.0 ^2.1 Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016
↑ ^3.0 ^3.1 Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015

Template:WH Template:WS

[radio-1] 1.0 ^1.1 Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016

[patho-2] 2.0 ^2.1 Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016

[patho2-3] 3.0 ^3.1 Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015

[1]

[2]

[3]

@@ Line 35: / Line 35: @@
 {|
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
+! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
-! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
+! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
-! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
+! rowspan="3" |'''Congenital'''
-! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
+! rowspan="3" |'''Acquied'''
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Microscopic findings
+! rowspan="3" |Demography
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis
+! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
+! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
+| colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard diiagnosis'''
+! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
+|-
+! colspan="3" |Symptoms
+! colspan="4" |Signs
+! colspan="3" |CBC
+! rowspan="2" |LFT
+! rowspan="2" |ESR/CRP
+! rowspan="2" |Histopathology
 |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
+!Appearance
-| style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Congenital'''
+!Fever
-| rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Acquied'''
+!Bleeding
+!BP
+!Hepatosplenomegaly
 !Lymphadenopathy
-!Fever
+!Other
-!CBC
+!WBC
-!LFT
+!Hb
-!ESR/CRP
+!Plt
-!Histopathology
-| colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]]
-| style="background: #F5F5F5; padding: 5px;" |_
 | style="background: #F5F5F5; padding: 5px;" |
 * HIV
@@ Line 65: / Line 72: @@
 * Organ transplantation
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 76: / Line 93: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]]
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 88: / Line 114: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Acroangiodermatitis
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 100: / Line 135: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Angiosarcoma]]
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 112: / Line 156: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]]
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 124: / Line 177: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]]
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 136: / Line 198: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]])
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 148: / Line 219: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Pigmented purpuric dermatosis
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 160: / Line 240: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyogenic]] [[granuloma]]
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 172: / Line 261: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 184: / Line 282: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]]
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 196: / Line 303: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcomatoid carcinoma
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 208: / Line 324: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Spindle cell]] hemangioendothelioma
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |

Kaposi's sarcoma differential diagnosis: Difference between revisions

Revision as of 03:56, 20 September 2018

Overview

Differentiating Kaposi's Sarcoma from other Diseases

References

Navigation menu